Recently, researchers found that EA pre-treatment improved the survival rate of rats with myocardial ischemia–reperfusion injury with reduced apoptosis and expressions of Cyt c and cleaved caspase 3 [30, 31]. This evidence concerns the gene CASP3 and myocardial ischemia.